Initial Results of Dose Finding in a First-in-human Phase 1 Study of a Novel Claudin 6 (CLDN6) Targeted Antibody Drug Conjugate (ADC) TORL-1-23 in Patients with Advanced Solid Tumors.

Gottfried Konecny,Andrea Wahner Hendrickson,Boris Winterhoff,Cinthiya Chander,Sanela Bilic,Simon Davenport, Adrine Chung, Lei-Lani Miller,Michael Press,Stephen Letrent,Dennis Slamon

Journal of Clinical Oncology（2023）

引用 0|浏览37
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要